Saudi Med J
-
To figure out the burden of chronic non-communicable diseases in Iraq on the health system through measuring the incidence and trend of these diseases. Methods: This descriptive study that was conducted between January 2016 and 2017, involved treatment data of chronic non-communicable diseases (hypertension, diabetes mellitus, ischemic heart disease, stroke, asthma and epilepsy). The data was collected from the registry of the Department of Health and Vital Statistics in the Ministry of Health, Babylon, Iraq, between 2000 and 2016. Results: The prevalence of diabetes mellitus had significantly increased from 19.58/1000 in the year 2000 to 42.27 in 2015 (p=0.0002). ⋯ The prevalence of cerebrovascular accidents showed a significant increase especially after 2008 (p=0.007), while ischemic heart diseases increased from 6.3/1000 in the year 2000 to 8.2/1000 in 2014 with no significant change. Conclusion: Non-communicable diseases in Iraq continue to show as a new developing burden after the 2003 war. Hypertension and diabetes mellitus demonstrate rapidly rising trends which may, in turn, enhance the occurrence of ischemic heart diseases and cerebrovascular accidents.
-
[No Abstract Available].
-
To evaluate the depressive and anxiety levels in allergic rhinitis (AR) and to investigate the relationship between depression and anxiety symptoms and depressive and anxious temperament features. Methods: The study design is cross-sectional. The study was conducted between January 2017 and January 2018. Patients (n=101) diagnosed with AR and healthy controls (n=74) were included in this study. ⋯ Participants with anxious temperament had 6.3-times (95% CI: 1.3-28.3) the risk for developing AR. Conclusion: Screening of temperament traits in AR patients may allow prediction of future depression and anxiety symptoms. These temperament traits may be mediators of depression and anxiety in AR patients. Depressive and anxious temperament traits may contribute to both depression and allergy.
-
To investigate the serum levels of nesfatin-1 and galanin in patients with metabolic syndrome (MetS), and also to show their association with the parameters of the disease. Methods: We performed a case-control study with 84 participants (44 patients with MetS diagnosed according to the American Heart Association/National Heart, Lung, and Blood Institute and International Diabetes Federation criteria and 40 control group) were recruited from King Abdulaziz University Hospital, Jeddah, Saudi Arabia, between October 2014 and June 2015. Anthropometric parameters, biochemical markers as well as nesfatin-1 and galanin were measured. Results: Nesfatin-1 levels were found to be significantly lower and galanin levels significantly higher in MetS group compared to the control group. A significant negative correlation between serum nesfatin-1 and weight, waist circumference, and body mass index were observed. A significant positive correlation between serum galanin and with fasting blood glucose, glycosylated hemoglobin, homeostasis model assessment-insulin resistance, and triglycerides. Conclusion: Our findings indicated a lower level of nesfatin-1 and a higher level of galanin in patients with MetS, suggesting a role of these neuropeptides in the pathogenesis of this disease.
-
[No Abstract Available].